Vineet Laboratories (NSE:VINEETLAB) Debt-to-Asset : 0.36 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:VINEETLAB Vineet Laboratories Ltd NSE:VINEETLAB
55 GF Score
Price ₹37.28
GF Value ₹10.08
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Vineet Laboratories Debt-to-Asset?

Vineet Laboratories NSE:VINEETLAB -0.24% 55 Debt-to-Asset is 0.36 as of Mar. 2026. GuruFocus rates NSE:VINEETLAB with a GF Score™ of 55/100 and a GF Value™ of ₹10.08 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Vineet Laboratories's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2026 was ₹351.2 Mil. Vineet Laboratories's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2026 was ₹102.1 Mil. Vineet Laboratories's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Mar. 2026 was ₹1,247.8 Mil. Vineet Laboratories's debt to asset for the quarter that ended in Mar. 2026 was 0.36.

Vineet Laboratories  (NSE:VINEETLAB) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Vineet Laboratories Debt-to-Asset Related Terms

Vineet Laboratories Debt-to-Asset Historical Data

* Premium members only.

The historical data trend for Vineet Laboratories's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vineet Laboratories Debt-to-Asset Chart

Vineet Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Debt-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.23 0.27 0.38 0.42 0.36

Vineet Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.42 0.45 0.47 0.00 0.36

NSE:VINEETLAB vs DOW: Debt-to-Asset Comparison

For the Chemicals subindustry, Vineet Laboratories's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vineet Laboratories Debt-to-Asset vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Vineet Laboratories's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Vineet Laboratories's Debt-to-Asset falls into.


NSE:VINEETLAB
55GF Score
Vineet Laboratories Ltd NSE:VINEETLAB
Debt-to-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vineet Laboratories Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Vineet Laboratories's Debt-to-Asset for the fiscal year that ended in Mar. 2026 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(351.188 + 102.066) / 1247.834
=0.36

Vineet Laboratories's Debt-to-Asset for the quarter that ended in Mar. 2026 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(351.188 + 102.066) / 1247.834
=0.36

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Debt-to-Asset →
What does a Debt-to-Asset of 0.36 mean?
Vineet Laboratories (NSE:VINEETLAB) has a Debt-to-Asset of 0.36 as of Mar. 2026. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on Vineet Laboratories and its competitors.
Is Vineet Laboratories' Debt-to-Asset too high?
Vineet Laboratories' current Debt-to-Asset is 0.36. Overall, Vineet Laboratories has a GF Score™ of 55/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vineet Laboratories' Debt-to-Asset compare to DOW?
Vineet Laboratories' Debt-to-Asset of 0.36 can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Asset for a Chemicals company?
A good Debt-to-Asset depends on the Chemicals industry context. However, Debt-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Asset mean?
A high Debt-to-Asset can signal that a stock is expensive relative to its fundamentals. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on Vineet Laboratories and its competitors. Vineet Laboratories's current Debt-to-Asset is 0.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vineet Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Vineet Laboratories (NSE:VINEETLAB) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹10.08, compared to a current price of ₹37.28 — trading 269.8% above its estimated fair value. The current Debt-to-Asset is 0.36. Vineet Laboratories' overall GF Score™ is 55/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Asset calculated?
Debt-to-Asset is calculated from a company's financial statements. For Vineet Laboratories (NSE:VINEETLAB), the current Debt-to-Asset is 0.36 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vineet Laboratories (NSE:VINEETLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Vineet Laboratories stock appears to be overvalued. The current stock price of ₹37.28 is trading 269.8% above its estimated GF Value™ of ₹10.08. GuruFocus considers Vineet Laboratories to be Significantly Overvalued.

Key valuation signals for NSE:VINEETLAB:

  • Debt-to-Asset: 0.36
  • GF Value™: ₹10.08 vs. price of ₹37.28 (269.8% above fair value)
  • GF Score™: 55/100 with 6 warning signs

No single metric tells the full story. See the NSE:VINEETLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vineet Laboratories Business Description

Other Exchanges 543298:India
Address 5-5-160, Malleswari Nilayam, Chintalakunta, Opposite Vishnu Theatre, L.B Nagar, Hyderabad, TG, IND, 500074
Vineet Laboratories Ltd is engaged in the business of Pharmaceutical intermediates and Fine chemicals. The products of the companies include Dimethyl phenoxy acetyl chloride, Dimethyl Phenoxy Acetic Acid, Nitrophenyl phosphate disodium salt, and others. Geographically, the company operates within India and outside India, with a majority of revenue coming from India. The company has one business segment, the manufacture of Drug Intermediates & Bulk Dugs.
55GF Score

Get the complete analysis for NSE:VINEETLAB

Debt-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹37.28
Price
₹10.08
GF Value